Autophagy: Cancer & Parkinson (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

September 19, 2020
Open Access

Vitexin suppresses renal cell carcinoma by regulating mTOR pathways

Translational Andrology and Urology
Yuhong LiMeng Wang
September 16, 2020
Open Access

From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins

Cristóbal Marrero-WinkensHermann M Schätzl
September 13, 2020
Open Access

Overexpression of Prolidase Induces Autophagic Death in MCF-7 Breast Cancer Cells

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
Ilona ZarebaJerzy Palka
September 15, 2020

Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance

Critical Reviews in Oncology/hematology
Sara M ElgendyHany A Omar
September 13, 2020

The Role of Autophagy in Targeted Therapy for Acute Myeloid Leukemia

Wenxin DuMeidan Ying
September 16, 2020
Open Access

Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies

International Journal of Molecular Sciences
Monica BenvenutoRoberto Bei
September 17, 2020
Open Access

A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer

Yuqing XiongAbie E Williams-Villalobo
September 21, 2020

The interaction mechanism between autophagy and apoptosis in colon cancer

Translational Oncology
Qingqiang XieXuefeng Li
September 16, 2020
Open Access

Autophagy as a therapeutic target in pancreatic cancer

British Journal of Cancer
Max PiffouxPhilippe A Cassier
September 19, 2020

DRAM1 plays a tumor suppressor role in NSCLC cells by promoting lysosomal degradation of EGFR

Cell Death & Disease
Ji GengZheng-Hong Qin
September 19, 2020

Chloroquine against malaria, cancers and viral diseases

Drug Discovery Today
Wenmin ZhouJianye Zhang
September 19, 2020

The function and mechanism of ferroptosis in cancer

Apoptosis : an International Journal on Programmed Cell Death
Ying WangQianming Chen
September 19, 2020

Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin

Advances in Nutrition
Mark F McCarty, Aaron Lerner
September 12, 2020
Open Access

Role of Photoactive Phytocompounds in Photodynamic Therapy of Cancer

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Kasipandi MuniyandiHeidi Abrahamse

Sign up to follow this feed and discover related papers.

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Antibody Therapeutics (MDS)

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. They have also been detected in several other neurodegenerative diseases, known as synucleopathies. Here is the latest research on alpha-synuclein antibody therapeutics.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Bovine Spongiform Encephalopathy (MDS)

Bovine spongiform encephalopathy is a neurodegenerative disease belonging to the transmissible spongiform encephalopathies, a group of diseases including sheep scrapie and human Creutzfeldt-Jakob disease. Here is the latest research.

Brain Imaging of Neural Circuits (MDS)

Neural circuits are groups of interconnected neurons which carry out specific functions when activated. Imaging these neural circuits allows researches to further elucidate their mechanisms and functions. Follow this feed to stay up to date on brain imaging of neural circuits.

Cerebral Palsy & Spasticity (MDS)

Spactic cereberal palsy is one of the most common types of cerebral palsy that stems from an upper motor neuron lesion in the brain. Discover the latest research on cerebral palsy and spasticity here.

© 2020 Meta ULC. All rights reserved